Daniel A. Osman, MD, breast cancer surgeon, program director, Miami Breast Cancer Conference, discusses the Miami Breast Cancer Conference (MBCC), which took place at the Fontainebleau Miami Beach hotel, in Florida, March 14-17, 2012.
During the span of the MBCC the central theme of the meeting has been to make everything you learn instantly applicable. As the conference enters its 29th year, this thesis remains true with a focus on the use of genomics and personalized medicine.
The esteemed presenter Charles M. Perou, PhD, discussed the topic of personalized medicine in his presentation on sequencing-based genomics. Perou led research in 2002, shortly after the genome was mapped, that discovered 5 biologically different subtypes of breast cancer. These subtypes have led to enhanced prognoses and treatments for breast cancer patients, which has helped herald a new era in breast cancer management.
